These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7942533)

  • 1. Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects.
    Dabaghi SF; Kamat SG; Payne J; Marks GF; Roberts R; Schafer AI; Kleiman NS
    Am J Cardiol; 1994 Oct; 74(7):720-3. PubMed ID: 7942533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in man.
    Böger RH; Bode-Böger SM; Gutzki FM; Tsikas D; Weskott HP; Frölich JC
    Clin Sci (Lond); 1993 May; 84(5):517-24. PubMed ID: 8504628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.
    Tohgi H; Tamura K; Kimura B; Kimura M; Suzuki H
    Stroke; 1988 Jun; 19(6):700-3. PubMed ID: 3376161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and ex vivo effects of aspirin in patients on a low-dose aspirin therapy.
    Voss R; Geissler BS; Tillmanns H; Matthias FR
    Thromb Res; 1993 Oct; 72(1):49-57. PubMed ID: 8122187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of enteric-coated, low-dose aspirin on parameters of platelet function.
    Van Hecken A; Juliano ML; Depré M; De Lepeleire I; Arnout J; Dynder A; Wildonger L; Petty KJ; Gottesdiener K; De Hoon JN
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1683-8. PubMed ID: 12197849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
    N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension.
    Louden KA; Broughton Pipkin F; Symonds EM; Tuohy P; O'Callaghan C; Heptinstall S; Fox S; Mitchell JR
    Br J Obstet Gynaecol; 1992 May; 99(5):371-6. PubMed ID: 1622907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term ultra-low-dose aspirin therapy and platelet function.
    Chetty N; Atkinson PM; Bradlow BA
    S Afr Med J; 1985 Aug; 68(5):307-9. PubMed ID: 3929399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose- and time-dependent antiplatelet effects of aspirin.
    Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
    Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oral aspirin versus topical applied methyl salicylate for platelet inhibition.
    Tanen DA; Danish DC; Reardon JM; Chisholm CB; Matteucci MJ; Riffenburgh RH
    Ann Pharmacother; 2008 Oct; 42(10):1396-401. PubMed ID: 18698012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why single daily dose of aspirin may not prevent platelet aggregation.
    Altman R; Scazziota A; Funes JC
    Thromb Res; 1988 Aug; 51(3):259-66. PubMed ID: 3140408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations and anti-platelet effects after low dose acetylsalicylic acid.
    Rosenkranz B; Frölich JC
    Prostaglandins Leukot Med; 1985 Sep; 19(3):289-300. PubMed ID: 3864170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
    Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
    Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin in pregnancy.
    Sibai BM; Mirro R; Chesney CM; Leffler C
    Obstet Gynecol; 1989 Oct; 74(4):551-7. PubMed ID: 2797631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet function by low-dose plain and micro-encapsulated acetylsalicylic acid.
    Waldemar G; Petersen P; Boysen G; Knudsen JB
    Thromb Res; 1988 Apr; 50(2):265-72. PubMed ID: 3134739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose effect of enteric-coated aspirin on platelet function and thromboxane generation in middle-aged men.
    Mohri H; Ohkubo T
    Ann Pharmacother; 1993 Apr; 27(4):405-10. PubMed ID: 8477113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.